Elsevier

Metabolism

Volume 44, Issue 5, May 1995, Pages 677-680
Metabolism

Acetyl-l-carnitine corrects the altered peripheral nerve function of experimental diabetes

https://doi.org/10.1016/0026-0495(95)90128-0Get rights and content

Abstract

Acetyl-l-carnitine (ALC) has been shown to facilitate the repair of transected sciatic nerves. The effect of ALC (50 mg/kg/d) on the diminished nerve conduction velocity (NCV) of rats with streptozotocin (STZ)-induced hyperglycemia of 3 weeks' duration was evaluated. The aldose reductase inhibitor, sorbinil, which is reported to normalize the impaired NCV associated with experimental diabetes, was used as a positive control. Aldose reductase inhibitors are thought to have an effect by decreasing peripheral nerve sorbitol content and increasing nerve myo-inositol. Treatment of STZ-diabetic rats with either ALC or sorbinil resulted in normal NCV. Sorbinil treatment was associated with normalized sciatic nerve sorbitol and myo-inositol; ALC treatment did not reduce the elevated sorbitol levels, but sciatic nerve myo-inositol content was no different from nondiabetic levels. Both ALC and sorbinil treatment of STZ-diabetic rats were associated with a reduction in the elevated malondialdehyde (MDA) content of diabetic sciatic nerve, indicating reduced lipid peroxidation. The beneficial effects of sorbinil and ALC on the altered peripheral nerve function associated with diabetes were similar, but their effects on the polyol pathway (frequently implicated in the pathogenesis of peripheral neuropathy) were different.

References (24)

  • JI Malone et al.

    Taurine prevents galactose-induced cataracts

    J Diabetic Complications

    (1993)
  • JH Thurston et al.

    Taurine: A role in osmotic regulation of mammalian brain and possible clinical significance

    Life Sci

    (1980)
  • RG Fariello et al.

    Systemic acetyl-l-carnitine elevates nigral levels of glutathione and GABA

    Life Sci

    (1988)
  • KRW Gillon et al.

    Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibition

    Diabetologia

    (1983)
  • DA Greene et al.

    Action of sorbinil in diabetic peripheral nerve: Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity

    Diabetes

    (1984)
  • AAF Sima et al.

    Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic bio-breeding rat

    J Clin Invest

    (1990)
  • MA Gieron et al.

    Improvement in peripheral nerve function after one year of sorbinil

    NeuroReport

    (1991)
  • AAF Sima et al.

    Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

    N Engl J Med

    (1988)
  • E Fernandez et al.

    Effects of l-carnitine, l-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats

    Neurol Res

    (1989)
  • E Fernandez et al.

    Studies on the degenerative and regenerative phenomena occurring after transection and repair of the sciatic nerve in rats: Effects of acetyl-l-carnitine

    Int J Clin Pharmacol Res

    (1990)
  • CC Rerup

    Drugs producing diabetes through damage of the insulin secreting cells

    Pharmacol Rev

    (1970)
  • JH Mayer et al.

    Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

    Diabetologia

    (1983)
  • Cited by (82)

    • Mechanisms of diabetic neuropathy: Schwann cells

      2014, Handbook of Clinical Neurology
      Citation Excerpt :

      In these studies, a variety of antioxidants and/or mitochondrial metabolites have been shown to ameliorate biochemical and functional nerve defects in experimental diabetes and, in a few cases, human diabetes. These include glutathione and a precursor for glutathione biosynthesis (Bravenboer et al., 1992; Love et al., 1996a), lipid-soluble antioxidants (Cameron et al., 1993, 1994), metal chelators (Cameron and Cotter, 2001; Love et al., 1996b), α-lipoic acid (Nagamatsu et al., 1995; Low et al., 1997; Cameron et al., 1998; Stevens et al., 2000; for review see also Vincent et al., 2004), and acetyl-L-carnitine (Cotter et al., 1995; Lowitt et al., 1995; Sima et al., 1996; De Grandis and Minardi, 2002). Importantly, these antioxidants have effects on indices of diabetic neuropathy that are similar to those of inhibitors of aldose reductase, nonenzymatic glycosylation, and protein kinase C, emphasizing the interrelationship of these metabolic defects.

    • Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity

      2012, Biochimica et Biophysica Acta - Molecular Basis of Disease
      Citation Excerpt :

      ALC has also been found to protect against lipid peroxidation and membrane breakdown [374,375]. In streptozotocin-induced diabetic rats, treatment with ALC improved nerve conduction velocities (the speed of signal through the nerves), and this was associated with a reduction in elevated malonyldialdehyde (MDA) content, an indicator of lipid peroxidation [376]. When administered via the perfusate to ischemia-reperfused rat hearts, carnitine derivatives were able to scavenge peroxyl or superoxide radicals [377].

    • Endocrinology

      2012, The Cat
    • Endocrinology: Progression over time

      2011, The Cat: Clinical Medicine and Management
    View all citing articles on Scopus

    Supported by the Health Program Office, Health and Rehabilitative Services, State of Florida, and Sigma Tau, Rome, Italy.

    View full text